Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1/2 3Phase 1 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3Dermatologic 2Thoracic 1Gastrointestinal 1Breast 1

Conditions

Sarcoma 3Melanoma 1

Interventions

Temozolomide 33Radiotherapy 32pembrolizumab 18Cyclophosphamide 18Irinotecan 16Gemcitabine 16Doxorubicin 16Nivolumab 11Docetaxel 11Sirolimus 10Imatinib Mesylate 10Ifosfamide 10Filgrastim 10Radiation 9Bevacizumab 9Vincristine 8Carboplatin 8pazopanib 7Everolimus 7temsirolimus 6atezolizumab 6Peripheral Blood Stem Cell Transplantation 6Etoposide 6fludarabine phosphate 5Vorinostat 5Specimen Handling 5Radiotherapy, Conformal 5PM 01183 5Ipilimumab 5Erlotinib Hydrochloride 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × talimogene laherparepvec × Sarcoma × Clear all
NCT04599062 2026-01-29

TVEC and Preop Radiation for Sarcoma (8 ml Dose)

University of Iowa

Phase 1/2 Active not recruiting
8 enrolled 8 charts
Sarcoma

Sarcoma

NCT02453191 2024-06-20

TVEC and Preop Radiation for Sarcoma (4 ml Dose)

University of Iowa

Phase 1/2 Completed
30 enrolled 12 charts
Sarcoma

Sarcoma

NCT03555032 2021-08-18

TITAN

Royal Marsden NHS Foundation Trust

Phase 1/2 Completed
15 enrolled
DermatologicSarcoma

Melanoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡